Orthogonal Methods

Orthogonal Analytics: How Much Characterization Is Enough?

David Alvaro, Ph.D.

Pharma's Almanac

SmartScale

Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model

Jesse McCool, Ph.D.

GBI Biomanufacturing

Data-Driven Mfg

Data-Driven Manufacturing and Digital Twins Across the Biologics Network

Jihyeon Oh; Hongwoo Joo

Samsung Biologics

Flow Chemistry

When Flow Chemistry Solves the Manufacturing Problem

Hiroaki Yasukouchi, Ph.D.

Kaneka

ASDs

The Evolving Science of Amorphous Solid Dispersions

Pharma's Almanac

CLD

Can Mammalian Cell-Line Engineering Become a High-Throughput Design Problem?

Pharma's Almanac

Bioprocessing

Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Pathfinder

Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?

Nice Insight

Formulation Models

Predictive Formulation: Can Modeling Reduce Empirical Development?

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?

Nice Insight

Viral CDMO

Choosing a CDMO That Can Grow with a Viral Program

Kai Lipinski, Ph.D.

Recipharm Advanced Bio

Viral Vectors

Gene Therapy Manufacturing After the Capacity Boom

David Alvaro, Ph.D.

Pharma's Almanac

Biocatalysis

When Does Biocatalysis Create the Better Manufacturing Process?

Yusho Kato

Kaneka

DS + DP Integration

Integrating Drug Substance and Drug Product to Reduce Risk Across Development

Dörthe Ackenhausen

IDT Biologika

Multi-Modality CDMO

The Rise of the Multi-Modality CDMO: Why Clients Need More Than Capacity

Kamal Preet

OneSource Specialty Pharma

Oncolytic Viruses

Turning Oncolytic Viruses into Manufacturable Cancer Therapies

Luisa Amoedo Otero

Recipharm Advanced Bio

DDC Development

Building Better Combination Products by Engaging Device Development Earlier

Loganathan S.

OneSource Specialty Pharma

Drug Shortage

What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage

David Alvaro, Ph.D.

Pharma's Almanac